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Abstract.  Approximately 23 % of the glycolytic en- 
zyme aldolase in the perinuclear region of Swiss 3T3 
cells is immobile as measured by FRAP. Previous 
studies suggest that the immobile fraction may be as- 
sociated with the actin cytoskeleton (Pagliaro,  L.  and 
D.  L.  Taylor.  1988. J.  Cell Biol.  107:981-991), and it 
has been proposed that the association of some glyco- 
lytic enzymes with the cytoskeleton could have func- 
tional significance, perhaps involving a fundamental 
relationship between glycolysis, cytoplasmic organiza- 
tion,  and cell motility. We have tested the effect of a 
key glycolytic inhibitor and an actin cytoskeletal 
modulator on the mobility of aldolase in living cells 
directly, using fluorescent analog cytochemistry and 
FRAP. We report here that the competitive hexokinase 
inhibitor 2-deoxyglucose releases the bound fraction of 
aldolase in 3T3 cells within  10 min,  and that this pro- 
cess is reversible upon washout of the inhibitor.  A 
similar result is produced with the actin-binding  agent, 
cytochalasin D.  These results are consistent with 
models in which glycolytic enzymes are not exclu- 
sively diffusion-limited,  soluble proteins, but may exist 
partially in the solid phase of cytoplasm. Such organi- 
zation has significant implications for both the 
modulation of cytoplasmic structure and for cellular 
metabolism. 
trR understanding  of cellular organization  and func- 
tion has evolved largely within the conceptual frame- 
work of studying either the structure of fixed cells or 
the activity of biochemical processes in relatively dilute, 
aqueous solutions.  These approaches have been enormously 
valuable in elucidating  the anatomy and possible biochemi- 
cal function of cells and their organelles,  but the dynamics 
of many cellular processes remain poorly understood, due 
to the loss of temporal information in ultrastructural  studies, 
and to the spatial averaging inherent  in biochemical experi- 
ments. Because of this, we believe that biochemical pathways 
must also be studied in living cells.  Such experiments  may 
reveal dynamic, but metabolically important, molecular as- 
sociations which result from weak interactions  at high intra- 
cellular molar concentrations.  Consequently,  studying  the 
temporal and spatial  dynamics of chemical and molecular 
processes in living ceils is essential for extending our under- 
standing of cellular functions (Taylor and Wang, 1980; Tay- 
lor et al.,  1984). 
We have recently mapped the distribution and mobility of 
two glycolytic enzymes in vivo as a model system for study- 
ing the intracellular  behavior of a biochemical pathway that 
is traditionally  characterized as existing entirely  in the solu- 
ble phase. Using fluorescent analog cytochemistry and digi- 
tal imaging microscopy, we presented evidence that aldolase, 
which bound to F-actin in vitro, was relatively concentrated 
in a microdomain around stress fibers in vivo (Pagliaro and 
Taylor, 1988), while enolase, which had no actin-binding ac- 
tivity in vitro, did not exhibit stress fiber localization in vivo 
(Pagliaro  et al.,  1989). Additionally,  FRAP measurements 
of the mobility and diffusion  coefficient of the fluorescent 
analogs  revealed that  aldolase had a  significant  immobile 
fraction in vivo, while enolase did not, again consistent with 
in vitro FRAP experiments.  The bound fraction of aldolase 
is released from F-actin in vitro when fructose-l,6-bisphos- 
phate  (the  substrate  for aldolase)  is added to gelled aldo- 
lase-F-actin mixtures.  Our data were consistent with models 
in which some glycolytic enzymes partition preferentially  in 
microdomains  around cytoskeletal elements (Clegg,  1984; 
Masters,  1984), or proposals that some glycolytic enzymes 
might exhibit 'functional duality; in which they possess both 
structural  and catalytic roles (Clarke et al.,  1985a).  Func- 
tional duality may contribute to the formation and regulation 
of cytoskeletal  structures;  organization  of glycolytic en- 
zymes around the cytoskeleton could, in turn, have signifi- 
cant implications  for metabolic regulation  and cell motility 
(Clarke  et al.,  1985b). 
There is growing evidence that glycolytic metabolism is 
closely associated with cell motility and cytoskeletal organi- 
zation.  In  a  series  of elegant  experiments  in  the  1950s, 
Kamiya and colleagues studied the rhythmic "shuttle-stream- 
ing" motility of the plasmodium of the aceUular slime mold 
Physarum. They found that inhibitors  of glycolytic metabo- 
lism (including iodoacetate and sodium fluoride) reversibly 
decreased the  motive  force of shuttle-streaming  by 75% 
within  2-3 min,  but that respiratory inhibitors  (including 
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only after 20 rain or more (Kamiya et al.,  1957). In 1976, 
Michl and colleagues showed that 2-deoxyglucose (2-DG) ~ 
selectively  inhibited  receptor-mediated  phagocytosis  in 
mouse peritoneal  macrophages  (Michl et al.,  1976a),  and 
that the inhibitory effects of 2-DG on phagocytosis were un- 
coupled from bulk ATP levels in these cells (Michl et al., 
1976b). Premature ischemic contracture due to ATP deple- 
tion in rat hearts has been shown to be more sensitive to 
glycolytic inhibitors (iodoacetate and 2-DG) than to respira- 
tory inhibition with atractyoloside (Bricknell et al.,  1981). 
In a study on rat epithelial ceils, Gibbins showed that 2-DG 
stopped cell motility within 1-2 min, but that cellular ATP 
was not significantly depleted for more than 20 rain (Gib- 
bins, 1982). Finally, it has been shown that cellular ATP lev- 
els decrease by 25 % within 1 min after perfusion of Xenopus 
tadpole  heart  endothelial  cells  with  2  ~g/ml  (,,o4  /zM) 
cytochaiasin D (CD), and that the ATP decrease is not due 
to reduced respiration (Tillmann and Bereiter-Hahn,  1986). 
These lines of evidence provide substantial support for the 
concept that the ATP source for some kinds of cell motility 
is preferentially giycolysis, rather than respiration.  Further, 
glycolytic activity may be modulated by reversible associa- 
tions with the solid phase of cytoplasm, including the actin- 
based cytoskeleton. 
Based on the above work, we hypothesized that if some 
giycolytic enzymes are preferentially localized around the 
actin cytoskeleton, and if such cytoskeletal localization is 
necessary for preferential use of giycolytic ATP for cell mo- 
tility,  then agents which inhibit giycolysis and cell motility 
might also affect enzyme localization.  Depletion of 'down- 
stream'  giycolytic intermediates  by 2-DG  could decrease 
catalytic  activity  and  significantly  affect enzyme-enzyme 
and (if they exist) enzyme-structural protein interactions in 
vivo. The simplest prediction based on our hypothesis is that 
inhibition of glycolysis with 2-DG would result in the loss 
of the immobile fraction of aldolase in vivo, but that enolase 
would be relatively unaffected by 2-DG. We have tested that 
prediction directly by performing FRAP experiments, both 
before and after perfusion with medium containing 2-DG, in 
individual  living  cells microinjected with fluorescent ana- 
logs of aldolase (rhodamine-labeled aldolase,  Rh-aldolase) 
and  enolase  (fluorescein-labeled  enolase,  Fl-enolase).  To 
directly evaluate the  role the actin cytoskeleton played in 
maintaining  the immobile fraction of Rh-aldolase in cells, 
we also performed FRAP experiments on cells before and af- 
ter perfusion with CD. 
Materials and Methods 
Cell Culture 
Swiss 3T3 fibroblasts (CCL92, American Type Culture Collection, Rock- 
ville, MD; passage numbers 120-131) were cultured in DME (Sigma Chem- 
ical  Co.,  St.  Louis,  MO)  on  40-mm-round  no.  1.5  coverslips  (Erie 
Scientific, Erie, PA) in 60-ram tissue culture dishes essentially as described 
previously (De Biasio et al.,  1987). To obtain cell polarity and spreading 
optimal  for  spatially  resolved photobleaching experiments,  cells  were 
"starved" in DME containing 0.2% FCS (Gibco Laboratories, Grand Is- 
1. Abbreviations used in this paper:  CD,  cytochalasin D, D~o, apparent 
cytoplasmic diffusion coefficient;  Fl--enolase, fluorescein-labeled  enolase; 
Rh-aldolase,  rhodamine'iabeled aidolase;  2-DG, 2-deoxyglucose. 
land, NY) beginning '~25 h before microinjection with fluorescent ana- 
log(s) at the start of an experiment. The medium in the dishes containing 
the eoverslips  was exchanged  for fresh, pH equilibrated DME containing 
10% FCS 30-45 rain before mieroinjection with fluorescent analog(s).  Im- 
mediately after mieroinjection, the medium was again gently exchanged 
with fresh DME  +  10%  FCS.  Cells were maintained at 37"C  during 
mieroinjection. During photobleaehing experiments,  cells were cultured in 
a modified (Bright et al., 1987) Sykes-Moore chamber (Bellco Glass, Inc., 
Vineland, NY) mounted on a thermoelectrically controlled stage (Rainin In- 
strument Company,  Inc., Woburn, MA). Additional  temperature control 
was provided by an air curtain (Sage Instruments, Cambridge, MA) regu- 
lated by  a  proportional controller (Cole-Parmer  Instrument Company, 
Chicago,  IL), which maintained the temperature of the microscope stage 
and objective at 37~ 
Fluorescent  Analog Cytocheraistry 
Fluorescent analogs of aldolase (Rh-aidolase) and enoiase (Fl-enolase) were 
prepared  and  evaluated  for biological  activity  as  described previously 
(Pagliaro  and Taylor, 1988; Pagliaro et al.,  1989). For these experiments, 
aldolase was  labeled with 5-(and-6)-earboxytetramethyl-rhodamine sue- 
einimidyl ester (Moleeuiar Probes, Inc., Eugene, OR), and euoiase was la- 
beled  with  5-(and-6)-carboxyfluorescein  sueeinimidyl ester  (Molecular 
Probes, Inc.). Cells were mieroinjeeted with ,o5-10% of a cell volume to 
a level of 2-4 % of endogenous  cellular aidolase or enolase,  respectively. 
The injection buffer consisted of 1 mM Pipes,  1 mM MgCI, 50 mM KCI, 
pH 7.3. 
Fluorescence  Redistribution After Photobleaching 
FRAP experiments were performed as described previously  (Pagliaro and 
Taylor, 1988; Pagliaro et ai.,  1989). For experiments in which Fl-enoiase 
and Rh-aidolase were eomicroinjected into cells; an argon ion laser (Spectra 
Physics, Inc., Mountain View, CA) was re-tuned between the 488- and 514- 
nm lines for successive FRAP measurements,  and the epifluorescence filters 
were changed accordingly. 
Inhibitor Experiments and Perfusion 
All cell perfusions were performed using a peristaltic pump to regulate the 
flow of 370C, CO2-equllibrated  medium to the inlet port of the modified 
Sykes-Moore chamber on the microscope stage. Perfusions were performed 
at a rate sufficient to provide a complete change of medium in the chamber 
and all associated  tubing in 30 s ("~2.5 ml/min); at this rate fluid shear in 
the chamber did not produce noticeable artifacts.  2-DG (Sigma Chemical 
Co.) was substituted for the glucose in DME (1 mg/mi) during preparation 
of otherwise identical batebes of medium, and 2-DG-DME was perfused 
into the chamber for 2-DG experiments.  CD (Sigma Chemical Co.) was dis- 
solved in a 1.0 mg/mi stock solution in DMSO (Sigma Chemical Co.), and 
diluted to a final concentration of 0.5 t~M (253 ng/ml) in DME for CD ex- 
periments. In some experiments,  the medium containing inhibitor (2-DG 
or CD) was washed out of the cell chamber with several changes of fresh, 
CO2-equllibrated  medium over a period of '~90 s, to evaluate the reversi- 
biLity of inhibitor effects on Rh-aldolase mobility. 
Results 
2-DG Releases the Immobile Fraction of  Aldolase 
In Vivo 
Perfusion of medium containing  1 mg/ml 2-DG into the cell 
chamber rapidly released the ,~21% bound fraction of Rh- 
aidolase in the perinuclear region of 3"1"3 cells, while the mo- 
bility of Rh-aldolase in the cell periphery, and the mobility 
of Fl-enolase, were not significantly affected. The data in Ta- 
ble I represent FRAP measurements taken 10-15 min after 
perfusion of 2-DG-DME into the cell chamber. By 10 min 
after perfusion, the response of cells to 2-DG was relatively 
uniform;  in the  first few minutes  after perfusion,  the  re- 
sponse was heterogeneous,  with  some "rapid  responders" 
(60-90 s) and some "slow responders" (90 s-10 min).  The 
apparent cytoplasmic diffusion coefficient (D~y~) of Rh-aido- 
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Control 
D37,cyto X  10  8*  %  Mobile 
+  2-DG 
D37,cyto  x  10  a  ~  Mobile 
Rh-Aldolase 
Perinuclear (8)~  14.3 •  6.7w  79.9 •  7.7  9.11 •  2.3  105.1 •  6.1 
Peripheral (7)  8.10 •  3.2  101.8 •  7.8  6.69 •  3.9  101.8 •  6.6 
FI-Enolase 
Perinuclear (3)  12.4 •  9.0  98.3 •  8.1  10.3 •  4.1  102.4 •  1.3 
Peripheral (3)  9.63 •  4.6  100.9 •  3.3  7.61 •  1.6  98.3 •  5.1 
* Apparent cytoplasmic diffusion coefficient (cm2/s) measured at 37~ 
$ Number of measurements used to calculate the mean. 
w Mean =i= the sample standard deviation. 
lase and Fl-enolase, both in the perinuclear region and the 
cell periphery, decreased slightly. No significant morpholog- 
ical changes were evident in these cells after 2-DG perfu- 
sion.  In  washout  experiments,  80-90%  of  the  control 
perinuclear bound fraction of Rh-aldolase returned by 60 
min after washout (Fig. 1), indicating that the effects of  2-DG 
were largely reversible, but the reversal was considerably 
slower than the initial effect. 
Cytochalasin D Releases the Immobile Fraction of 
Aldolase In Vivo 
We  used  CD  to  study  the  effect of disrupting  the  actin 
cytoskeleton on the mobility of the bound fraction of aldo- 
lase.  Perfusion of medium containing 0.5/zM CD into the 
cell chamber caused a  rapid and complete release of the 
bound fraction of Rh-aldolase. Fig. 2 B shows the mobility 
of Rh-aldolase and Fl-enolase in the perinuclear region of 
two different representative cells after perfusion with CD 
and  subsequent washout.  Four other experiments yielded 
similar results (data not shown). In the example shown, the 
immobile fraction of Rh-aldolase decreased from 25.5 % be- 
fore CD perfusion to 2.3% by 90 s after perfusion. When 
CD was subsequently washed out of the chamber, 80-90% 
of the control perinuclear immobile fraction of Rh-aldolase 
returned after 20 min. Fl-enolase was 100% mobile, and its 
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Figure 1. Effect of  2-DG washout on the perinuclear immobile frac- 
tion of Rh-aldolase in a typical cell. Timescale represents minutes 
after CD washout. 
mobility was not significantly affected by either CD perfu- 
sion or subsequent washout. The D~o values of Rh-aldolase 
and Fl-enolase were not significantly affected by CD perfu- 
sion (Fig. 2 A).  The measured D~y~ of Fl-enolase (90,000 
mol wt) was  slightly higher than the D~o of Rh-aldolase 
(160,000 tool wt), as expected, due to the larger hydrody- 
namic radius of aidolase. 
Discussion 
Inhibition of  Glycolysis,  Enzyme Mobility, and the 
Actin Cytoskeleton 
Our  data  demonstrate  that  2-DG  reversibly releases  the 
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I~gure 2. Effect of CD perfusion and washout on the mobility and 
Dcyto of Rh-aldolase (s) and Fl-enolase (o) in the perinuclear re- 
gion of representative cells. FRAP was used to measure the Dr 
(A) and mobile fraction (B). Tunes after perfusion of  the cell cham- 
ber with medium containing CD, and after subsequent washout are 
shown. D~o values are expressed in cm2/s x  108. 
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living Swiss 3T3 fibroblasts within 10 rain after perfusion, 
but that it does not significantly affect the mobility of FI- 
enolase.  This  finding  is  consistent with  models  in which 
some  glycolytic  enzymes  are  associated  with  the  actin 
cytoskeleton  in  an  activity-dependent  manner  (Wilson, 
1988). The reversal of the effects of 2-DG on aldolase mobil- 
ity was considerably  slower and  somewhat less  complete 
than the initial effect, but it was substantial and reproducible. 
CD inhibits elongation of actin filaments at the barbed end 
and binds to actin monomers,  promoting dimer formation 
and ATP hydrolysis (Goddette and Frieden,  1986; Cooper, 
1987).  CD probably changes the critical concentration for 
acfin polymerization  in vivo,  and  may affect cytoplasmic 
ATP concentrations. There is evidence that CD decreases the 
mean length of actin filaments in vivo, effecting a solation 
and contraction of the actin-myosin II system (Kolega et al., 
1991), which results in fragmenting and altered organization 
of the actin cytoskeleton (Schliwa,  1982). Our experiments 
with CD demonstrated that it resulted in rapid mobilization 
of the bound fraction of Rh-aldolase in vivo, but that it had 
no significant effect on Fl-enolase. We predicted that, if the 
actin cytoskeleton was involved in immobilizing the bound 
fraction of aldolase in our experiments, then disrupting actin 
organization  with CD should increase the mobility of Rh- 
aldolase,  but not Fl-enolase.  Our data are consistent with 
that prediction, and with models in which a fraction of aldo- 
lase  is bound to the actin  cytoskeleton in vivo.  The  CD- 
induced reorganization of the actin cytoskeleton may cause 
the release of aldolase from actin filaments, or may result in 
small oligomeric actin fragments which remain bound to al- 
dolase. In either case, we would expect to see a decrease in 
the bound fraction of aldolase using FRAP. 
Both 2-DG and CD caused a small, global decrease in the 
D~  of both Rh-aldolase and Fl-enolase. Although it is not 
clear that this decrease is significant, due to the errors inher- 
ent in measurements in vivo, it has been a consistent finding 
in our experiments,  and it is possible that it reflects an in- 
crease  in  cytoplasmic  apparent  viscosity.  In  the  case  of 
2-DG,  release  of bound aldolase molecules  (and perhaps 
other glycolytic enzymes) could cause increased cytoplasmic 
micro-viscosity; in the case of CD, an increase in the number 
of actin molecules (due to fragmenting  of filaments) could 
contribute to increased cytoplasmic micro-viscosity. Alter- 
natively, if CD action in vivo results in aldolase bound to 
small oligomeric actin fragments,  we would also expect to 
measure a slightly decreased D~y~ value with FRAP. 
Aldolase as an Ambiquitous Enzyme 
Ambiquitous  enzymes  were originally  defined by Wilson 
(1978) as having kineticaUy distinct subsets which partition 
between soluble and membrane-bound forms in cells. Am- 
biquity provides a model for regulation of cytoplasmic en- 
zyme activity, using a mechanism analogous to allostery, in 
which binding of an enzyme to a structural element regulates 
its catalytic activity. Hexokinase was subsequently identified 
as the prototype ambiquitous enzyme (Wilson,  1980), and 
evidence has recently been presented that hexokinase parti- 
tions between bound and free fractions in vivo (Laursen et 
al.,  1990) and that 2-DG modulates the association of hexo- 
kinase with mitochondria in fixed cells (Lynch et al.,  1991). 
The structural element(s) to which an ambiquitous enzyme 
binds are not limited to membrane-associated structures; in- 
deed, relatively weak interactions  among several enzymes 
and cytoskeletal components could be significant at the high 
concentrations found in cytoplasm (Walsh and Knull, 1987). 
The  binding  of aldolase  to  the  actin  cytoskeleton  could 
modulate the activity of al~olase; conversely, inhibition of 
glycolysis with 2-DG could modulate the ratio of bound/free 
aldolase. The data in this paper are consistent with the last 
model, and we believe that our evidence suggests that aldo- 
lase displays ambiqultous behavior in 3T3 cells. Enolase has 
no intracellular  bound fraction,  and shows no evidence of 
ambiquitous behavior. 
Ambiquity may account, in pan, for a paradoxical finding 
in this study and in our previous work (Pagliaro and Taylor, 
1988). Initially, we predicted that the high actin concentra- 
tion in the cell periphery would result in a greater bound 
fraction of aldolase relative to the perinuclear  region.  We 
have consistently observed the opposite; a bound fraction of 
aldolase in the perinuclear region, and 100% mobility in the 
cell periphery.  In addition,  however, we have also consis- 
tently measured a  substantial  (40-50%)  lower D~o in the 
cell periphery  relative to the perinuclear  region.  It is not 
clear  from  our  data  that  the  reduced  peripheral  Doy~ is 
significant,  due to the large errors inherent in FRAP mea- 
surements in vivo, but transient  interactions between aldo- 
lase and the actin cytoskeleton,  which are faster than  the 
time resolution of our FRAP instrument,  could account for 
the  lower peripheral  D~  we measured.  Thus,  the bound 
fraction of aldolase in the perinuclear region may represent 
a  kinetically  distinct,  downregulated  subset  of aldolase, 
while the fully mobile (but lower D~) peripheral measure- 
merits may average brief bound and mobile diffusion compo- 
nents. Such rapid, transient interactions could represent dy- 
namic ambiquitous behavior of aldolase. 
Do Glycolytic Enzymes Exhibit Functional Duality? 
Functional duality, as defined by Clarke et al. (1985a), de- 
scribes a more general case than does ambiquity: a glycolytic 
enzyme could possess significant biological activities in ad- 
dition to its primary catalytic role. Thus,  the bound phase 
of aldolase may serve other functions typical of actin-binding 
proteins; indeed, aldolase may behave as a true actin-binding 
protein under  some metabolic conditions  (Maciver et al., 
1991).  It is clear that aldolase is an actin-gelation factor in 
vitro (Clarke et al.,  1985a; Pagliaro and Taylor, 1988), and 
it could be involved in cytoplasmic integration or tension- 
transmission in vivo (Luby-Phelps et al.,  1988). Functional 
duality could associate glycolytic metabolism with cytoplas- 
mic structure  and cell motility  in a broader physiological 
context than conventional metabolic models allow for. 
ATP Metabolism and Cytoskeleton Regulation 
There is substantial evidence that ATP metabolism is closely 
related to the regulation and stability of the actin cytoskele- 
ton (Bershadsky and Gelfand,  1983). A variety of respira- 
tory inhibitors  (oligomycin, CCCP, sodium azide and 2,4- 
DNP) caused a gradual (90 min) disorganization of the actin 
cytoskeleton in mouse embryo fibroblasts,  when the cells 
were cultured in glucose-free medium (Bershadsky et al., 
1980).  When glucose was present in the culture medium, 
however, the actin distribution was not affected, showing that 
glycolytic ATP alone is sufficient to maintain the integrity 
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strated that actin-containing  bundles had differential  sensi- 
tivity to cellular ATP levels; stress fibers were more resistant 
to ATP depletion (using 2-DG together with respiratory in- 
hibitors) than cleavage rings (Sanger et al.,  1983).  Normal 
stress  fiber  patterns  were  restored  after  inhibitors  were 
washed  out in  a  subsequent  report  from  the  same  group 
(Glascott et al.,  1987). Finally, it was reported that primary 
Xenopus  tadpole heart cells were more sensitive to metabolic 
inhibitors than was an established cell line from the same 
source (Bereiter-Hahn  et al.,  1984).  These studies provide 
evidence  that  glycolytic  ATP metabolism  is  essential  for 
modulating the actin cytoskeleton. Further, they suggest that 
such modulation could be specific  for stress  fibers,  rather 
than other actin-based structures, and that it may be develop- 
mentally regulated. 
Although  we  know  far more  about the  organization  of 
cytoplasm today than we did when the term "cytosol" was 
operationally defined (Lardy,  1965),  our working assump- 
tions about intrinsically  cytoplasmic biochemistry (such as 
glycolytic  metabolism)  have evolved  relatively  little.  It is 
clear,  for example, that weak interactions can become very 
important given the high molar concentrations and complex 
equilibria of cytoplasm. We believe that experiments in liv- 
ing cells will be essential for further defining the organiza- 
tion and regulation of metabolic pathways and all cellular 
biochemical events. 
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